Johnson & Johnson hit with $572 million opioid ruling — what happens now?

Johnson & Johnson is appealing the decision, which could be the first of many legal battles.
A judge has ordered Johnson & Johnson to pay $572 million in connection with the opioid crisis in Oklahoma.
Photo by Mario Tama/Getty Images

FDA approves new Johnson & Johnson drug for depression

Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an…
Janssen Pharmaceutica

Why St. Louis was named a 'judicial hellhole'

Mar 6, 2017
Big jury verdicts have made Missouri a target for tort reform.
The American Tort Reform Association says Missouri courts make it too easy for people to sue corporations. Above, the Civil Courts building in St. Louis.
Maria Altman, St. Louis Public Radio

The economics behind the rush for an Ebola vaccine

Oct 22, 2014
Believe it or not, experts say the profit motive is secondary.

Johnson & Johnson to pay $2.2 billion in Risperdal settlement

by
Nov 5, 2013
In one of the biggest cases of health care fraud ever, J&J is being fined for improperly marketing a drug for treating schizophrenia.

MID-DAY UPDATE: Flight delays and electric cars

Oct 19, 2010
Flight delays don't only cost you a lot of frustration and time -- they also happen to cost the country more than $32 billion a year. Jeremy Hobson...